Back to today’s briefing

Story perspectives

New Alzheimer’s Drug Clears 90% of Harmful Plaques

7/31/2025

48 11

Summary

Story summary

A groundbreaking drug, trontinemab, is making waves in the fight against Alzheimer's by effectively clearing harmful amyloid plaques. In trials, an impressive 90% of patients saw significant plaque reduction within just 28 weeks. Experts are hopeful it could not only halt progression but also protect at-risk individuals, potentially available through the NHS with fewer side effects and lower costs.

1 of 1

Story summary

A groundbreaking drug, trontinemab, is making waves in the fight against Alzheimer's by effectively clearing harmful amyloid plaques. In trials, an impressive 90% of patients saw significant plaque reduction within just 28 weeks. Experts are hopeful it could not only halt progression but also protect at-risk individuals, potentially available through the NHS with fewer side effects and lower costs.